Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-12-04

Clinical Trial Update: Intranasal Ketorolac Tromethamine (SPRIX) as a Short Term Pain Management of Post-Vasectomy Pain [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating intranasal ketorolac tromethamine (Sprix) for short-term pain management after vasectomy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sprix intranasal ketorolac tromethamine (ketorolac tromethamine)

Snippet

Sponsor: Citrus Valley Medical Research, Inc. | Conditions: Post Vasectomy Pain | Phase 4 | Status: UNKNOWN